---
title: "UBS Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285787280.md"
description: "In a report released on May 7, from UBS maintained a Buy rating on Zai Lab Ltd, with a price target of HK$27.00. The company’s shares closed last Thursday at HK$16.20.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zai Lab Ltd with a €3.04 average price target."
datetime: "2026-05-09T00:38:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285787280.md)
  - [en](https://longbridge.com/en/news/285787280.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285787280.md)
---

# UBS Reaffirms Their Buy Rating on Zai Lab Ltd (1ZLB)

In a report released on May 7, from UBS maintained a Buy rating on Zai Lab Ltd, with a price target of HK$27.00. The company’s shares closed last Thursday at HK$16.20.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Zai Lab Ltd with a €3.04 average price target.

### Related Stocks

- [ZLAB.US](https://longbridge.com/en/quote/ZLAB.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [09688.HK](https://longbridge.com/en/quote/09688.HK.md)

## Related News & Research

- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Roth MKM Sticks to Their Buy Rating for Capricor Therapeutics (CAPR)](https://longbridge.com/en/news/286497683.md)
- [LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)](https://longbridge.com/en/news/286648286.md)
- [Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)](https://longbridge.com/en/news/286588262.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)